Oral Presentation 11 Asthma |
13:30-14:50 Pearl |
||
---|---|---|---|
Chair | Sang-Heon Kim (Hanyang University, Korea) | ||
13:30-13:40 | OP 11-1 |
Dupilumab Efficacy in Patients with GINA-Defined Type 2 Asthma: Traverse
William W. Busse (University of Wisconsin School of Medicine and Public Health, USA)
|
|
13:40-13:50 | OP 11-2 |
Prevalence of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts
Hyonsoo Joo (The Catholic University of Korea, Korea)
|
|
13:50-14:00 | OP 11-3 |
Comparative Efficacy and Safety Between Budesonide-formoterol and Fluticasone-salmeterol Combination Inhalers for Asthma Management: Retrospective Analysis from the Common Data Model
Seong-Dae Woo (Chungnam National University, Korea)
|
|
14:00-14:10 | OP 11-4 |
Clinical Characteristics of Korean Severe Asthma Patients
Joon Young Choi (The Catholic University of Korea, Korea)
|
|
14:10-14:20 | OP 11-5 |
Rootletin is a Marker for Asthma Exacerbation in Patients with Asthma: Implication for Diesel Exhaust Particles
seon-muk choi (Soonchunhyang University, Korea)
|
|
14:20-14:30 | OP 11-6 |
The Prevalence of and Factors Associated with Influenza Vaccination in Patients with Asthma in Korea
Sang Hyuk Kim (Sungkyunkwan University, Korea)
|
|
14:30-14:40 | OP 11-7 |
Cardiovascular and Cerebrovascular Mortality in Asthma Patients with Preceding Exacerbation
Soojoung Yu (Yonsei University, Korea)
|
|
14:40-14:50 | OP 11-8 |
Pharmacovigilance Studies of Oral Salbutamol in Chronic Asthmatic Patients in Different Clinical Setups of Hyderabad, Sindh, Pakistan
Mudassar Iqbal Arain (University of Sindh, Pakistan)
|